Synthace Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $34.6M

  • Investors
  • 21

Synthace General Information

Description

Developer of a laboratory automation platform designed to reshape biological experimentation. The company's platform removes the wrangling of lab data through the dynamic generation, capture, and structuring of data with metadata, connects the experiment with other tools in the digital ecosystem, and helps to plan and execute multifactorial experiments, enabling biologists to conduct codeless reprogramming of liquid handlers and visual stimulation before executing experiments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Westworks
  • 195 Wood Lane, 1th Floor
  • London W12 7FQ
  • England, United Kingdom
+44 020
Primary Industry
Enterprise Systems (Healthcare)
Corporate Office
  • The Westworks
  • 195 Wood Lane, 1th Floor
  • London W12 7FQ
  • England, United Kingdom
+44 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Synthace Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series C) 16-Nov-2021 $34.6M Completed Generating Revenue
12. Accelerator/Incubator 23-Jan-2019 Completed Generating Revenue
11. Later Stage VC (Series B) 12-Dec-2018 Completed Generating Revenue
10. Later Stage VC 01-Jun-2018 Completed Generating Revenue
9. Grant 01-Dec-2017 Completed Generating Revenue
8. Later Stage VC (Series A) 01-Sep-2017 Completed Generating Revenue
7. Later Stage VC 01-Dec-2016 Completed Generating Revenue
6. Early Stage VC 01-Dec-2014 Completed Generating Revenue
5. Seed Round 24-Sep-2013 $2.07M $3.02M Completed Generating Revenue
4. Angel (individual) 12-Apr-2013 $944K Completed Generating Revenue
To view Synthace’s complete valuation and funding history, request access »

Synthace Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C2 Preferred
Series C1 Preferred
Ordinary
Series B
2017 Convertible Preference
Ordinary
2017 Convertible Preference
2017 Convertible Preference
Convertible Preference 3,796,414 $0.001363 $0.68 $0.68 1x $0.68 4.84%
Ordinary 652,261 $0.001363 $0.68 $0.68 3x $0.68 0.83%
To view Synthace’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Synthace Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a laboratory automation platform designed to reshape biological experimentation. The company's platform rem
Enterprise Systems (Healthcare)
London, United Kingdom
37 As of 2026

Boston, MA

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Synthace Competitors (7)

One of Synthace’s 7 competitors is SnapGene, a Formerly PE-Backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
SnapGene Formerly PE-Backed Boston, MA
TetraScience Venture Capital-Backed Boston, MA
Tempus AI Formerly VC-backed Chicago, IL
Owkin Venture Capital-Backed Paris, France
Benchling Venture Capital-Backed San Francisco, CA
You’re viewing 5 of 7 competitors. Get the full list »

Synthace Patents

Synthace Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202307650-D0 Systems and method for integration of generative artificial intelligence with desing and automation of expriments Inactive 22-May-2023
GB-202404764-D0 Accessible active learning and llms to enable faster iteration in process development and r&d Inactive 14-Apr-2023
GB-202305498-D0 Methods for optimisation of liquid handling processes Inactive 14-Apr-2023
WO-2024213903-A1 Methods for optimisation of liquid handling processes Inactive 14-Apr-2023
EP-4085257-A1 Systems and methods for improved automation of laboratory processes Active 31-Dec-2019 G01N35/0092
To view Synthace’s complete patent history, request access »

Synthace Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Synthace Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Razor Capital Venture Capital Minority
Plug and Play Accelerator/Incubator
Startup Creasphere Accelerator/Incubator Minority
ICONIQ Growth Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

Synthace FAQs

  • When was Synthace founded?

    Synthace was founded in 2011.

  • Where is Synthace headquartered?

    Synthace is headquartered in London, United Kingdom.

  • What is the size of Synthace?

    Synthace has 37 total employees.

  • What industry is Synthace in?

    Synthace’s primary industry is Enterprise Systems (Healthcare).

  • Is Synthace a private or public company?

    Synthace is a Private company.

  • What is the current valuation of Synthace?

    The current valuation of Synthace is .

  • What is Synthace’s current revenue?

    The current revenue for Synthace is .

  • How much funding has Synthace raised over time?

    Synthace has raised $89.2M.

  • Who are Synthace’s investors?

    , Razor Capital, Plug and Play, Startup Creasphere, and ICONIQ Growth are 5 of 21 investors who have invested in Synthace.

  • Who are Synthace’s competitors?

    SnapGene, TetraScience, Tempus AI, Owkin, and Benchling are some of the 7 competitors of Synthace.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process